369 related articles for article (PubMed ID: 14984376)
21. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
[TBL] [Abstract][Full Text] [Related]
22. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease.
Gao Q; Hogezand RA; Lamers CB; Verspaget HW
Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330
[TBL] [Abstract][Full Text] [Related]
23. Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
Keating GM; Perry CM
BioDrugs; 2002; 16(2):111-48. PubMed ID: 11985485
[TBL] [Abstract][Full Text] [Related]
24. Successful treatment with infliximab and methotrexate of pyostomatitis vegetans associated with Crohn's disease.
Bens G; Laharie D; Beylot-Barry M; Vergier B; Noblesse I; Beylot C; Amouretti M
Br J Dermatol; 2003 Jul; 149(1):181-4. PubMed ID: 12890215
[TBL] [Abstract][Full Text] [Related]
25. Long-term oral tacrolimus therapy in refractory to infliximab fistulizing Crohn's disease: a pilot study.
González-Lama Y; Abreu L; Vera MI; Pastrana M; Tabernero S; Revilla J; Durán JG; Escartin P
Inflamm Bowel Dis; 2005 Jan; 11(1):8-15. PubMed ID: 15674108
[TBL] [Abstract][Full Text] [Related]
26. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
[TBL] [Abstract][Full Text] [Related]
27. Mucosal healing with methotrexate in Crohn's disease: a prospective comparative study with azathioprine and infliximab.
Laharie D; Reffet A; Belleannée G; Chabrun E; Subtil C; Razaire S; Capdepont M; de Lédinghen V
Aliment Pharmacol Ther; 2011 Mar; 33(6):714-21. PubMed ID: 21235604
[TBL] [Abstract][Full Text] [Related]
28. An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease.
Sabate JM; Villarejo J; Lemann M; Bonnet J; Allez M; Modigliani R
Aliment Pharmacol Ther; 2002 Jun; 16(6):1117-24. PubMed ID: 12030953
[TBL] [Abstract][Full Text] [Related]
29. Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis.
Colombel JF; Reinisch W; Mantzaris GJ; Kornbluth A; Rutgeerts P; Tang KL; Oortwijn A; Bevelander GS; Cornillie FJ; Sandborn WJ
Aliment Pharmacol Ther; 2015 Apr; 41(8):734-46. PubMed ID: 25728587
[TBL] [Abstract][Full Text] [Related]
30. Infliximab improves quality of life in the short-term in patients with fistulizing Crohn's disease in clinical practice.
Cadahia V; García-Carbonero A; Vivas S; Fuentes D; Niño P; Rebollo P; Rodrigo L
Rev Esp Enferm Dig; 2004 Jun; 96(6):369-74; 374-8. PubMed ID: 15230666
[TBL] [Abstract][Full Text] [Related]
31. Retreatment and maintenance therapy with infliximab in fistulizing Crohn's disease.
Rodrigo L; Pérez-Pariente JM; Fuentes D; Cadahia V; García-Carbonero A; Niño P; de Francisco R; Tojo R; Moreno M; González-Ballina E
Rev Esp Enferm Dig; 2004 Aug; 96(8):548-54; 554-8. PubMed ID: 15449986
[TBL] [Abstract][Full Text] [Related]
32. Infliximab for the treatment of fistulas in patients with Crohn's disease.
Present DH; Rutgeerts P; Targan S; Hanauer SB; Mayer L; van Hogezand RA; Podolsky DK; Sands BE; Braakman T; DeWoody KL; Schaible TF; van Deventer SJ
N Engl J Med; 1999 May; 340(18):1398-405. PubMed ID: 10228190
[TBL] [Abstract][Full Text] [Related]
33. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease.
Lichtenstein GR; Yan S; Bala M; Blank M; Sands BE
Gastroenterology; 2005 Apr; 128(4):862-9. PubMed ID: 15825070
[TBL] [Abstract][Full Text] [Related]
34. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
[TBL] [Abstract][Full Text] [Related]
35. Advances in medical therapy for Crohn's disease.
D'Haens G; Daperno M
Curr Gastroenterol Rep; 2002 Dec; 4(6):506-12. PubMed ID: 12441041
[TBL] [Abstract][Full Text] [Related]
36. Response to infliximab is related to disease duration in paediatric Crohn's disease.
Lionetti P; Bronzini F; Salvestrini C; Bascietto C; Canani RB; Dé Angelis GL; Guariso G; Martelossi S; Papadatou B; Barabino A
Aliment Pharmacol Ther; 2003 Aug; 18(4):425-31. PubMed ID: 12940928
[TBL] [Abstract][Full Text] [Related]
37. Infliximab in the treatment of Crohn's disease: a user's guide for clinicians.
Sandborn WJ; Hanauer SB
Am J Gastroenterol; 2002 Dec; 97(12):2962-72. PubMed ID: 12492177
[TBL] [Abstract][Full Text] [Related]
38. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease.
Van Assche G; Vanbeckevoort D; Bielen D; Coremans G; Aerden I; Noman M; D'Hoore A; Penninckx F; Marchal G; Cornillie F; Rutgeerts P
Am J Gastroenterol; 2003 Feb; 98(2):332-9. PubMed ID: 12591051
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcome of non-fistulizing (ulcers, stricture) perianal Crohn's disease in patients treated with infliximab.
Bouguen G; Trouilloud I; Siproudhis L; Oussalah A; Bigard MA; Bretagne JF; Peyrin-Biroulet L
Aliment Pharmacol Ther; 2009 Oct; 30(7):749-56. PubMed ID: 19583709
[TBL] [Abstract][Full Text] [Related]
40. Long-term treatment of rectovaginal fistulas in Crohn's disease: response to infliximab in the ACCENT II Study.
Sands BE; Blank MA; Patel K; van Deventer SJ;
Clin Gastroenterol Hepatol; 2004 Oct; 2(10):912-20. PubMed ID: 15476155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]